AstraZeneca (AZN.O) said its collaboration with Oracle (ORCL.N) will cover core
therapeutic areas including oncology, cardiovascular, renal and metabolic
diseases, respiratory, immunology and rare diseases.
2026-10-20
AstraZeneca (AZN.O) said its collaboration with Oracle (ORCL.N) will cover core
therapeutic areas including oncology, cardiovascular, renal and metabolic
diseases, respiratory, immunology and rare diseases.